Scholars@Duke publication: Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease

Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease

Publication , Conference

DeArmey, S; Kishnani, PS

Published in: Molecular Genetics and Metabolism

February 2016

Published version (DOI) Publisher Link

Duke Scholars

Author Priya Sunil Kishnani Pediatrics, Medical Genetics

Published In

Molecular Genetics and Metabolism

DOI

10.1016/j.ymgme.2015.12.235

ISSN

1096-7192

Publication Date

February 2016

Volume

117

Issue

Start / End Page

S39 / S39

Publisher

Elsevier BV

Related Subject Headings

Genetics & Heredity
3202 Clinical sciences
3105 Genetics

Citation

APA

Chicago

ICMJE

MLA

NLM

DeArmey, S., & Kishnani, P. S. (2016). Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease. In Molecular Genetics and Metabolism (Vol. 117, pp. S39–S39). Elsevier BV. https://doi.org/10.1016/j.ymgme.2015.12.235

DeArmey, Stephanie, and Priya S. Kishnani. “Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease.” In Molecular Genetics and Metabolism, 117:S39–S39. Elsevier BV, 2016. https://doi.org/10.1016/j.ymgme.2015.12.235.

DeArmey S, Kishnani PS. Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease. In: Molecular Genetics and Metabolism. Elsevier BV; 2016. p. S39–S39.

DeArmey, Stephanie, and Priya S. Kishnani. “Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease.” Molecular Genetics and Metabolism, vol. 117, no. 2, Elsevier BV, 2016, pp. S39–S39. Crossref, doi:10.1016/j.ymgme.2015.12.235.

DeArmey S, Kishnani PS. Electrocardiograph findings when screening for initiation of oral substrate reduction therapy with eliglustat for treatment of Gaucher disease. Molecular Genetics and Metabolism. Elsevier BV; 2016. p. S39–S39.

Published In

Molecular Genetics and Metabolism

DOI

10.1016/j.ymgme.2015.12.235

ISSN

1096-7192

Publication Date

February 2016

Volume

117

Issue

Start / End Page

S39 / S39

Publisher

Elsevier BV

Related Subject Headings

Genetics & Heredity
3202 Clinical sciences
3105 Genetics